Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1995-04-12
2000-01-18
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424452, 424457, 424458, 424461, 424462, 424479, 424494, 424495, 424497, 424474, 5147723, 514781, 514822, 514824, A61K 936, A61K 958, A61K 962, A61K 3162
Patent
active
060155779
ABSTRACT:
The specification describes a pharmaceutical combination consisting of dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing this pharmaceutical combination and the use thereof for the controlled prevention of clot formation.
REFERENCES:
patent: 4367217 (1983-01-01), Gruber et al.
patent: 4694024 (1987-09-01), Weithmann et al.
Lancet 1979, Dec. 8: 1213-1216.
Prostaglandins and Medicine, 4, 439-447, 1980.
Prostaglandins, Leukotrienes and Medicine, 12: 235-244, 1983.
Lancet 1987, Dec. 12;2(8572):1351-4.
Thromb Res 1998 Sep. 15;92(1 Suppl 1);S1-6.
Neurology 1998 Sep.;51(3 Suppl 3):S17-9.
Neurology 1998 Sep.;51(3 Suppl 3):S15-6.
Eisert Wolfgang
Gruber Peter
Devlin Mary-Ellen M.
Page Thurman K.
Raymond Robert P.
Spear James M.
Stempel Alan R.
LandOfFree
Pharmaceutical compositions containing dipyridamole or mopidamol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing dipyridamole or mopidamol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing dipyridamole or mopidamol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-561345